EvoNK Micrometastasis Immunotherapy
What kind of disease is micrometastatic cancer?
Limitations of existing treatments Differences between LACELLIC
Why EvoNK is different
EvoNK immune cell therapy
The core of intensive treatment for micrometastatic cancer proposed by LACELLIC
LACELLIC Micrometastasis Cancer Medical Tour
LACELLIC Medical Tour Package Micrometastatic cancer (MRD, Minimal Residual Disease) refers to cancer cells that remain minutely in the body even after surgery or chemotherapy.
Although it is small enough to not be detected with existing imaging tests, it can become the starting point of recurrence over time, so management of the time after treatment is a concept that is discussed together.
Even if the cancer is the same and the stage is the same, the location and activity of the remaining cancer varies from person to person, so it may be difficult to say that treatment is complete simply by removing visible lesions.
In conventional treatment, imaging diagnosis, regular follow-up, and standard anticancer drugs have been the mainstays. However, there have been clear limitations in completely finding and removing microscopic cells that are not captured in images, and discussions have continued on how to fill this gap.
Recently, research is continuing on how to use immune cells to access cells that cause residual cancer and recurrence. Tracking Invisible Cells - LACELLIC's EvoNK Approach
LACELLIC's EvoNK Immunotherapy Ⅱ is a program designed to manage these residual cancers.
The approach is to maximize the immune response against tumor cells hidden invisibly by intensively administering EvoNK cells cultured in a highly activated state. Here are the points LACELLIC looks at in the micrometastasis program:
• Perfect tracking of micrometastatic cancer (MRD) • Target removal of cancer stem cells (CSC) • Accurate target recognition based on CDNV • Overcoming tumor microenvironment (TME)
The actual configuration is examined along three axes: By combining LACELLIC's unique CDNV-based technology, NK cells can more accurately find hidden cancer tissues. Highly activated EvoNK cells are administered intensively in batches to maximize the immune response to tumor cells.
The goal is to target removal of residual cancer that causes recurrence after surgery and chemotherapy and cancer stem cells (CSCs) that are highly resistant to treatment.
However, micrometastasis management depends on the type and stage of the primary cancer.
The approach is different depending on the treatment you have already received and your current systemic and immune status.
Rather than uniformly applying a specific method, priority is given to comprehensively examining the current condition, consulting with medical staff, and reviewing individual application and plans.
The existing standard chemotherapy/radiation treatment and regular follow-up should be continued at the discretion of the medical staff, and the cell program is not a replacement for this. Do not stop treatment arbitrarily and be sure to consult your doctor.
Medical tour information for overseas patients
For overseas patients, not only medical treatment and treatment, but also the schedule before and after visiting Korea must be considered.
LACELLIC provides consultation regarding treatment schedules and medical tourism so that overseas patients can more conveniently prepare their domestic treatment schedule.
Information on movement and stay after arrival at the airport, remote tracking of immunity levels and follow-up care after returning home, and connection to global partner clinics in Southeast Asia, the Middle East, and the Americas are also provided.
The specific scope of support may vary depending on the patient's schedule and program and can be confirmed through prior consultation. Micrometastasis management and cell programs may be applied differently depending on the individual's condition.
EvoNK also prioritizes the process of confirming applicability based on sufficient testing and consultation with medical staff. Treatment effectiveness may vary depending on the individual.
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
